Shares of HIMS experienced a dramatic drop today following website the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by over 10%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that